Burden of Hepatitis B and Syphilis Coinfections on HIV Treatment Outcome in Ethiopia

What is it about?

In this study, researchers documented the burden of two sexually transmitted co-infections, HBV and syphilis, and evaluated their impact on HIV treatment outcome. They found that the co-infection rate of HBV and syphilis was 5.5% and 2.2% among people living with HIV in Ethiopia, with significant variation in prevalence across regional states. Both HBV and syphilis co-infections were associated with increased virologic failure, immune suppression, and inflammation. The study identified a relatively higher burden of HBV co-infection among males (7.8%) compared to women (4.8%) and highlighted the need for targeted interventions. The study concluded that HBV and syphilis co-infections hinder HIV virologic and immunologic outcomes, and immunosuppression and virologic failure in HIV patients can also lead to syphilis reactivation.

Featured Image

Why is it important?

This study is important because it documents the burden of two sexually transmitted co-infections (HBV and syphilis) and evaluates their impact on HIV treatment outcome in Ethiopia. Understanding the prevalence and consequences of these co-infections is crucial for designing targeted interventions and improving the overall health of people living with HIV. Key Takeaways: 1. The co-infection rate of HBV and syphilis was 5.5% and 2.2% among people living with HIV in Ethiopia, with significant variation in prevalence across regional states. 2. The odds of HBV co-infection were higher among males, adolescents, and syphilis positives, while syphilis co-infection was higher in patients with CD4 count <500 cells/mm3 and those who did not initiate HAART. 3. Both HBV and syphilis co-infections were significantly associated with increased virologic failure, immune suppression, and inflammation. 4. The study highlights the need for specific program interventions to address the most affected population segments, such as targeted vaccination for highly affected males and adolescents. 5. HBV and syphilis co-infections hinder HIV virologic and immunologic outcomes, and immunosuppression and virologic failure in HIV patients can lead to syphilis reactivation, which is a threat for a high surge of syphilis in HIV positives with poor treatment compliance and responses.